Stull Steven T sold $975K of CPAY

Stull Steven T sold 2,357 shares of CORPAY, INC. (CPAY) at an average of $413.62 ($412.91–$414.62, $0.97M total) across 3 trades on 2026-08-20.

Original reporting
SEC EDGAR · Stull Steven T
Published Aug 21, 2026, 8:14 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 21, 2026, 8:40 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CPAY
Bearish
medium confidence
Mentioned
$CPAY
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CPAYBearishLow
01

Why it matters

The disclosed sale provides fresh data on insider holdings, useful for short‑term traders.

02

Market read

New insider sale adds modest negative sentiment; likely limited price impact.

03

What to watch

No 10b5‑1 plan and the director still holds a sizable stake, indicating continued confidence.

Relevance 5/10Novelty 4/10Timing: today

Background

Form 4 filings disclose insider transactions; director sales are monitored for potential signals.

Company-level read

Ticker impact

$CPAYBearishMedium confidence
Context

Director Steven T. Stull sold 2,357 shares of Corpay Inc for $974,910 on 2026-08-20, reducing his holding to 21,241 shares.

Expected impact

Modest downward pressure in the near term.

Evidence & confidence

The sale size (~$1M) is modest for a director, but any insider sell can trigger short-term sell‑offs, especially given the lack of a 10b5‑1 plan.

Market effects

Minimal impact on the fintech/payment services sector.

No significant regional effect.

Limited to investors tracking insider activity.

Counterpoint

The sale could be routine portfolio diversification rather than a negative signal.

Key entities

  • Corpay Inc

    Provider of payment solutions, ticker CPAY.

  • Steven T. Stull

    Director of Corpay Inc who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CPAYMed

What Corpay (CPAY) Said on Its Q3 Earnings Call

Corpay (CPAY) reported Q3 gross margin at 30.4%, up from Q2 but down annually. Cash position was CAD 50.6M. Acquired AISPECO for airborne sensors. Expects revenue synergies sooner. Plans to scale manufacturing and expand commercial/defense businesses. Corpay provides corporate payment solutions.

$CPAYMedAI 8/10

Corpay 3Q 2026: Revenue $1.38B, EPS $5.66 — 10-Q Summary

Corpay reported 3Q 2026 revenue of $1.38B, up 17.9% YoY, and net income of $378.42M, up 36.2% YoY. Growth was driven by organic spend and transaction volumes, new sales, and acquisitions. Higher operating expenses and other costs partly offset gains. Management expects liquidity to meet needs for the next 12 months.

$CPAYHighAI 8/10

Corpay (CPAY) Q3 2026 Earnings Call Transcript

Corpay (CPAY) raised Q4 2026 revenue guidance to $1.37B and cash EPS to $7.65, up 27%. Full-year 2026 revenue is expected to rise 18%, with cash EPS up over 30%. For 2027, Corpay anticipates 9-11% organic revenue growth. The company has divested noncore businesses, using proceeds for share buybacks, and plans to allocate $2B in free cash flow to acquisitions or buybacks. Corporate Payments segment growth is expected to remain in the high teens.

$CPAYMed

Corpay Q3 Earnings Call Highlights

Corpay (NYSE:CPAY) expects 9-11% organic revenue growth in 2027, with $2B in free cash flow for acquisitions or share repurchases. The company divested noncore businesses in 2026, using proceeds for buybacks. Alpha and Avid are expected to contribute over $1.40 in combined cash EPS accretion in 2026. Corpay aims to compound adjusted EPS by over 20% annually through 2029.